Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet-activating factor in infants at risk for necrotizing enterocolitis.

S S Rabinowitz1, P Dzakpasu, S Piecuch

  • 1Children's Medical Center of Brooklyn, the Division of Gastroenterology, Department of Anatomy and Cell Biology, State University of New York - Health Science Center at Brooklyn, USA.

The Journal of Pediatrics
|January 10, 2001
PubMed
Summary

Platelet-activating factor (PAF) levels, measured as PAF-lipids (PAF-LL), can help diagnose necrotizing enterocolitis (NEC) in infants. Elevated PAF-LL indicates NEC severity and can predict its development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Peripheral Neuropathy After Chronic Alcohol Exposure in Mice: Impact of sex, total intake and duration and alcohol metabolism.

bioRxiv : the preprint server for biology·2025
Same author

The ESCRT-0 subcomplex component Hrs/Hgs is a master regulator of myogenesis via modulation of signaling and degradation pathways.

BMC biology·2021
Same author

Effects of High-Intensity Interval Running Versus Cycling on Sclerostin, and Markers of Bone Turnover and Oxidative Stress in Young Men.

Calcified tissue international·2019
Same author

Amyotrophic lateral sclerosis in Huntington disease gene carrier.

Revue neurologique·2017
Same author

Ethno-Cultural Considerations in Cardiac Patients' Medication Adherence.

Clinical nursing research·2016
Same author

[Tardive dyskinesia and second generation antipsychotics: a review of four cases].

Revue medicale de Bruxelles·2016

Area of Science:

  • Neonatal Medicine
  • Biochemistry
  • Pediatric Gastroenterology

Background:

  • Platelet-activating factor (PAF) is a phospholipid linked to perinatal diseases like necrotizing enterocolitis (NEC).
  • Understanding PAF's role in NEC is crucial for early diagnosis and management.

Purpose of the Study:

  • To investigate the correlation between PAF-lipid (PAF-LL) levels and the incidence and severity of NEC in at-risk infants.
  • To assess the diagnostic and prognostic value of PAF-LL measurements in NEC.

Main Methods:

  • Blood samples were collected from 164 infants at risk for NEC across three neonatal intensive care units.
  • Baseline PAF-LL levels were measured, with serial measurements taken for infants who developed NEC.

Main Results:

Related Experiment Videos

  • Infants with stage II and III NEC showed significantly elevated peak PAF-LL (mean 13.6 ng/mL) compared to those without NEC (mean 2.03 ng/mL).
  • PAF-LL levels correlated with NEC severity, increasing with disease progression and decreasing with resolution.
  • A PAF-LL cutoff of 10.2 ng/mL demonstrated 100% positive predictive value for NEC.

Conclusions:

  • PAF-LL measurements can serve as a valuable adjunct to clinical and radiographic assessments for NEC diagnosis.
  • PAF-LL may play a significant role in the pathogenesis and progression of necrotizing enterocolitis.